Come alongside a mission to make the OR safer, simpler, and smarter.
Bezalel Innovations is raising a $500,000 Phase I round through a special purpose vehicle. Your investment helps bring ACTS from a proven concept to the operating rooms where it belongs.
The mission
Re-engineer the ordinary so clinicians can focus on what matters.
The pneumatic tourniquet is one of the most common devices in surgery — and one of the least improved. ACTS replaces the cart, compressor, tubing, and cuff inventory with a wireless, self-contained system that is cleaner, faster, and easier to manage.
Patient first
Lower, measured occlusion pressure and a sterile, self-contained cuff mean less risk and less handling between cases.
Clinically grounded
Built by a surgeon who spent fifteen years in the OR and knows exactly where the legacy tourniquet falls short.
Market ready
FDA Class I, 510(k) exempt. A $646.48M global market in 2026 with 3M+ U.S. procedures a year waiting for a real alternative.
The thesis
A large, ordinary market that nobody has re-engineered.
The pneumatic tourniquet is used in millions of procedures a year and has been essentially unchanged for decades. ACTS removes the compressor, the tubing, and three of the five cuff sizes — and replaces the capital sale with a subscription.
- 3M+ U.S. surgeries a year rely on a pneumatic tourniquet.
- $646.48M global surgical tourniquet market in 2026, growing at a 7.4% CAGR.
- FDA Class I, 510(k) exempt — a materially shorter path to market.
- Recurring revenue through ACTS-as-a-Service, not one-time capital sales.
- Surgeon-founded, with intellectual property pending on the core architecture.
$500K
Phase I round size
SPV
Single-purpose vehicle for this round
Class I
510(k) exempt regulatory pathway
Use of proceeds
Engineering & tooling
Complete the wireless in-cuff pump architecture and move from working prototype to production-intent tooling.
Verification & quality
Design verification testing, biocompatibility, and the quality system documentation that supports a Class I launch.
Pilot deployments
Place ACTS in ambulatory surgery centers, gather real utilization data, and convert pilots into subscriptions.
IP & commercial
Continue prosecution of pending filings and expand field representation beyond our current six territories.
Exclusive fund partner
This SPV is managed by Sandbox.
Bezalel Innovations has an exclusive partnership with Sandbox, who serves as the manager of this special purpose vehicle. Sandbox handles fund formation, subscription documents, capital calls, and ongoing investor reporting — so you are investing through an experienced, professionally administered structure rather than a one-off arrangement.
Access to this SPV is privileged to Bezalel Innovations and its invited network. Allocation is limited to the Phase I round.
Exclusive partner
Sandbox is our sole SPV partner for this round — a dedicated, exclusive relationship with Bezalel Innovations.
Professional administration
Fund formation, subscription documents, and compliance are handled end to end by Sandbox.
Privileged access
Participation is offered through Bezalel Innovations and its invited network, not a public raise.
Ongoing reporting
Capital calls, distributions, and investor updates flow through Sandbox's managed process.
How it works
The SPV process, from interest to investment.
We have kept the process simple and transparent. Submitting the form is only the first step — it is not a commitment to invest.
Express interest
Submit the short form below with your name, email, and a brief message. There is no commitment at this stage.
Review materials
Our team will send you the SPV overview, subscription terms, and the information you need to evaluate the opportunity.
Complete subscription
If you choose to participate, Sandbox handles the subscription documents, capital call, and investor onboarding.
Invest & follow along
Your capital joins the Phase I round and helps ACTS move toward the operating room. Updates come through Sandbox.
Investor FAQ
Questions about the SPV.
Answers to the most common questions we receive from prospective investors.
Next steps
Ready to learn more?
If the mission, market, and SPV structure align with your investment goals, we would love to send you the full materials. The form below is the fastest way to get started.
- Submit the short interest form
- Receive SPV materials by email
- Schedule a call with our team
- Complete subscription through Sandbox
Not ready to invest yet?
You can still stay informed. Follow us on LinkedIn, Facebook, or Instagram for updates on ACTS development, pilot deployments, and company milestones.
Prefer email?
Send questions directly to our team and we will respond as soon as possible.
info@bezalelinnovations.comSPV interest
Tell us you would like to participate.
Share a little about yourself and we will follow up with the SPV materials and a conversation. No commitment is made by submitting this form.
Prefer email?
info@bezalelinnovations.com